文献速递腹部MR

术前钆塞酸增强MRI预测LI-RADS 5类肝细胞癌的侵袭性病理特征

Preoperative gadoxetic acid-enhanced MRI predicts aggressive pathological features in LI-RADS category 5 hepatocellular carcinoma.
PubMed 文献 · Clin Radiol · 2022-06-20

研究纳入2018年2月至2021年9月236例疑似肝癌的肝硬化或乙肝病毒感染成人患者,术前1个月内行MRI,最终112例病理确诊≤5 cm肝癌,其中31.3%为高分级HCC、37.5%存在微血管侵犯。多因素分析显示,镶嵌结构、冠状面强化和瘤内血管是高分级HCC的独立预测因素;非光滑肿瘤边缘、冠状面强化和肝胆期瘤周低信号是MVI的独立预测因素。

要点

  • 镶嵌结构、冠状面强化、瘤内血管是高分级HCC的独立预测因素。
  • 非光滑肿瘤边缘、冠状面强化、肝胆期瘤周低信号是MVI的独立预测因素。
  • 冠状面强化同时预测高分级HCC和MVI。

核心结论

  • 在单个≤5 cm的LR-5 HCC高危成人患者中,镶嵌结构、冠状面强化和瘤内血管是高分级HCC的独立预测因素;非光滑肿瘤边缘、冠状面强化和肝胆期瘤周低信号独立预测MVI。

研究设计与样本

  • 研究纳入2018年2月至2021年9月236例疑似肝癌的肝硬化或乙肝病毒感染成人患者,术前1个月内行MRI,最终112例病理确诊≤5 cm肝癌;采用单因素和多因素逻辑回归分析显著MRI征象和AFP水平对高分级HCC和MVI的预测价值。

关键影像表现/征象

  • 镶嵌结构(OR=6.031;95%CI:1.366,26.626;p=0.018)是高分级HCC的独立预测因素。
  • 冠状面强化(OR=5.878;95%CI:1.471,23.489;p=0.012)是高分级HCC的独立预测因素。
  • 瘤内血管(OR=5.278;95%CI:1.325,21.020;p=0.018)是高分级HCC的独立预测因素。
  • 非光滑肿瘤边缘(OR=10.237;95%CI:1.547,67.760;p=0.016)是MVI的独立预测因素。
  • 肝胆期瘤周低信号(OR=10.322;95%CI:2.733,38.986;p=0.001)是MVI的独立预测因素。

诊断标准与关键数值

  • 高分级HCC的独立预测因素:镶嵌结构OR=6.031(95%CI:1.366,26.626;p=0.018)、冠状面强化OR=5.878(95%CI:1.471,23.489;p=0.012)、瘤内血管OR=5.278(95%CI:1.325,21.020;p=0.018)。
  • MVI的独立预测因素:非光滑肿瘤边缘OR=10.237(95%CI:1.547,67.760;p=0.016)、冠状面强化OR=3.800(95%CI:1.152,12.531;p=0.028)、肝胆期瘤周低信号OR=10.322(95%CI:2.733,38.986;p=0.001)。

临床应用与阅片要点

  • 在术前钆塞酸增强MRI上,对单个≤5 cm的LR-5 HCC,可关注镶嵌结构、冠状面强化和瘤内血管以提示高分级HCC。
  • 非光滑肿瘤边缘、冠状面强化和肝胆期瘤周低信号可提示MVI。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate whether Liver Imaging Reporting and Data System (LI-RADS) imaging features and non-LI-RADS imaging features can predict aggressive pathological features in adult patients with hepatocellular carcinoma (HCC).

MATERIALS AND METHODS: From February 2018 to September 2021, 236 adult patients with cirrhosis or hepatitis B virus infection in which liver cancer was suspected underwent MRI within 1 month before surgery. Significant MRI findings and alpha-fetoprotein (AFP) level predicted high-grade HCC and microvascular invasion (MVI) by univariate and multivariate logistic regression models.

RESULTS: The study included 112 patients with histopathologically confirmed liver cancer (≤5 cm), 35 of whom (31.3%) high-grade HCC and 42 of 112 (37.5%) patients had MVI. Mosaic architecture (odds ratio [OR] = 6.031; 95% confidence interval [CI]: 1.366, 26.626; p=0.018), coronal enhancement (OR=5.878; 95% CI: 1.471, 23.489; p=0.012), and intratumoural vessels (OR=5.278; 95% CI: 1.325, 21.020; p=0.018) were significant independent predictors of high-grade HCC. A non-smooth tumour margin (OR=10.237; 95% CI: 1.547, 67.760; p=0.016), coronal enhancement (OR=3.800; 95% CI: 1.152, 12.531; p=0.028), and peritumoural hypointensity on the hepatobiliary phase (HBP; OR=10.322; 95% CI: 2.733, 38.986; p=0.001) were significant independent predictors of MVI.

CONCLUSION: In high-risk adult patients with single LR-5 HCC (≤5 cm), mosaic architecture, coronal enhancement, and intratumoural vessels are independent predictors of high-grade HCC. Non-smooth tumour margin, coronal enhancement, and peritumoural hypointensity on HBP independently predicted MVI.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Liang, Shi, Gao, et al. Preoperative gadoxetic acid-enhanced MRI predicts aggressive pathological features in LI-RADS category 5 hepatocellular carcinoma. Clin Radiol. 2022. PMID: 35738938. doi:10.1016/j.crad.2022.05.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。